Morning Movers: Hims & Hers sinks after FDA calls tirzepatide shortage over

Check out this morning’s top movers from around Wall Street, compiled by The Fly.

HIGHER –

• EVgo (EVGO) up 22% after announcing that it has received a conditional commitment for a loan guarantee of up to $1.05B of debt financing, from the U.S. Department of Energy, or DOE, Loan Programs Office under its Title 17 program to accelerate expansion of its fast-charging network in community locations across the U.S.

UP AFTER EARNINGS –

• Nano Dimension (NNDM) up 2%

DOWN AFTER EARNINGS –

• Constellation Brands (STZ) down 1%
• Levi Strauss (LEVI) down 11%

LOWER –

• Hims & Hers (HIMS) down 10% after the FDA determined that Eli Lilly’s (LLY) GLP-1 weight-loss drug shortage has been resolved
• Wolfspeed (WOLF) down 6% after Mizuho downgraded shares to Underperform from Neutral with a price target of $8, down from $17
• Novavax (NVAX) down 3% after the company clarified that while it has anticipated the COVID-19 vaccination market in the U.S. will be similar to last year, it has neither updated nor reaffirmed its full year 2024 financial guidance issued on August 8
• Academy Sports (ASO) down 1% after Evercore ISI downgraded the stock to In Line from Outperform with a price target of $60, down from $65